These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

793 related items for PubMed ID: 27718216

  • 21. Predictors of outcome in paediatric IgA nephropathy with regard to clinical and histopathological variables (Oxford classification).
    Edström Halling S, Söderberg MP, Berg UB.
    Nephrol Dial Transplant; 2012 Feb; 27(2):715-22. PubMed ID: 21750154
    [Abstract] [Full Text] [Related]

  • 22. The effects of cytotoxic therapy in progressive IgA nephropathy.
    Shin JH, Lee JE, Park JH, Lim S, Jang HR, Kwon GY, Huh W, Jung SH, Kim YG, Oh HY, Kim DJ.
    Ann Med; 2016 Feb; 48(3):171-81. PubMed ID: 27031662
    [Abstract] [Full Text] [Related]

  • 23. Treatment of severe Henoch-Schönlein and immunoglobulin A nephritis. A single center experience.
    Edström Halling S, Söderberg MP, Berg UB.
    Pediatr Nephrol; 2009 Jan; 24(1):91-7. PubMed ID: 18931859
    [Abstract] [Full Text] [Related]

  • 24. [Value of serum IgA/C3 ratio in the diagnosis of IgA nephropathy and its correlation with the clinicopathological features].
    Zhu S, Li Y, Zhou S, Wei Q, Deng K, Wang X, Li B, Liu J, Liu X, Zhang Y, Shao X, Liu A, Wu B, Zhao Z, Xu X, Lin H, Liu Q, Li J, Wang H, Zhou Q, Zhu C, Lv D, Xia Y, Zou H.
    Nan Fang Yi Ke Da Xue Xue Bao; 2015 Dec; 35(12):1683-8. PubMed ID: 26714897
    [Abstract] [Full Text] [Related]

  • 25. Predictive value of sub classification of focal segmental glomerular sclerosis in Oxford classification of IgA nephropathy.
    Yu F, Zhu X, Yuan S, Chen X, Li Z, Qu Z, Liu H, Sun L, Liu F.
    Ann Med; 2021 Dec; 53(1):587-595. PubMed ID: 33825605
    [Abstract] [Full Text] [Related]

  • 26. Could mesangial C3 deposition be an independent prognostic marker in immunoglobulin A nephropathy?
    Cetinkaya H, Gursu M, Yazici H, Cebeci E, Eren N, Altiparmak MR, Akcay OF, Sahin G, Dheir H, Basturk T, Atilgan KG, Aydemir N, Turgutalp K, Yilmaz M, Sirali SK, Tatar E, Boz EG, Mirioglu S, Kazan S, Aydin E, Aydin Z, Turkmen K, Kutlay S, Karagoz F, Ogutmen MB, Ozturk S, Ozkan O, Yildiz N, Dincer T, Yasar E, Gok M, Turkmen A, Dede F, Derici U.
    J Nephrol; 2024 May; 37(4):923-932. PubMed ID: 37947938
    [Abstract] [Full Text] [Related]

  • 27. Clinical usefulness of the Oxford classification in determining immunosuppressive treatment in IgA nephropathy.
    Yoon CY, Chang TI, Kang EW, Lim BJ, Kie JH, Kee YK, Kim H, Park S, Yun HR, Jung SY, Jhee JH, Kwon YE, Oh HJ, Park JT, Yoo TH, Kang SW, Jeong HJ, Han SH.
    Ann Med; 2017 May; 49(3):217-229. PubMed ID: 27764976
    [Abstract] [Full Text] [Related]

  • 28. IgA Nephropathy in Children: A Multicenter Study in Poland.
    Mizerska-Wasiak M, Turczyn A, Such A, Cichoń-Kawa K, Małdyk J, Miklaszewska M, Pietrzyk J, Rybi-Szumińska A, Wasilewska A, Firszt-Adamczyk A, Stankiewicz R, Szczepańska M, Bieniaś B, Zajączkowska M, Pukajło-Marczyk A, Zwolińska D, Siniewicz-Luzeńczyk K, Tkaczyk M, Gadomska-Prokop K, Grenda R, Demkow U, Pańczyk-Tomaszewska M.
    Adv Exp Med Biol; 2016 May; 952():75-84. PubMed ID: 27573641
    [Abstract] [Full Text] [Related]

  • 29. Serum IgA/C3 and glomerular C3 staining predict severity of IgA nephropathy.
    Kawasaki Y, Maeda R, Ohara S, Suyama K, Hosoya M.
    Pediatr Int; 2018 Feb; 60(2):162-167. PubMed ID: 29178575
    [Abstract] [Full Text] [Related]

  • 30. Serum IgA/C3 ratio: a useful marker of disease activity in patients with IgA nephropathy.
    Torikoshi K, Endo T, Tsukamoto T, Yasuda T, Yasuda Y, Kawamura T, Matsuo S, Suzuki Y, Muso E.
    Int Urol Nephrol; 2024 Oct; 56(10):3389-3396. PubMed ID: 38829466
    [Abstract] [Full Text] [Related]

  • 31. Long-term renal survival and undetected risk factors of IgA nephropathy in Chinese children-a retrospective 1243 cases analysis from single centre experience.
    Wu H, Fang X, Xia Z, Gao C, Peng Y, Li X, Zhang P, Kuang Q, Wang R, Wang M.
    J Nephrol; 2020 Dec; 33(6):1263-1273. PubMed ID: 32507961
    [Abstract] [Full Text] [Related]

  • 32. Is it possible to predict the evolution of IgAN? Validation of the IgA nephropathy progression calculator and its relationship with MEST-C score in our population.
    Martín-Penagos L, Benito A, Oviedo MV, López Del Moral Cuesta C, Martín López J, Gómez Román J, López-Mejías R, Fernandez-Fresnedo G, Ruíz San Millán JC, Rodrigo Calabia E.
    Nefrologia (Engl Ed); 2019 Dec; 39(5):523-530. PubMed ID: 30902505
    [Abstract] [Full Text] [Related]

  • 33. First-year GFR slope and long-term renal outcome in IgA nephropathy.
    Lee K, Shin J, Park J, Hwang S, Jang HR, Huh W, Kwon GY, Kim YG, Oh HY, Lee JE, Kim DJ.
    Eur J Clin Invest; 2018 Jun; 48(6):e12936. PubMed ID: 29660832
    [Abstract] [Full Text] [Related]

  • 34. Serum C3/C4 ratio is a novel predictor of renal prognosis in patients with IgA nephropathy: a retrospective study.
    Pan M, Zhou Q, Zheng S, You X, Li D, Zhang J, Chen C, Xu F, Li Z, Zhou Z, Zhang J.
    Immunol Res; 2018 Jun; 66(3):381-391. PubMed ID: 29850970
    [Abstract] [Full Text] [Related]

  • 35. Supportive Versus Immunosuppressive Therapy of Progressive IgA nephropathy (STOP) IgAN trial: rationale and study protocol.
    Eitner F, Ackermann D, Hilgers RD, Floege J.
    J Nephrol; 2008 Jun; 21(3):284-9. PubMed ID: 18587715
    [Abstract] [Full Text] [Related]

  • 36. Factors predicting progression of IgA nephropathies.
    Coppo R, D'Amico G.
    J Nephrol; 2005 Jun; 18(5):503-12. PubMed ID: 16299675
    [Abstract] [Full Text] [Related]

  • 37. Predictors for progression in immunoglobulin A nephropathy with significant proteinuria.
    Hwang HS, Kim BS, Shin YS, Yoon HE, Song JC, Choi BS, Park CW, Yang CW, Kim YS, Bang BK.
    Nephrology (Carlton); 2010 Mar; 15(2):236-41. PubMed ID: 20470285
    [Abstract] [Full Text] [Related]

  • 38. Is There a Role for IgA/C3 Ratio in IgA Nephropathy Prognosis? An Outcome Analysis on An European Population.
    Stefan G, Stancu S, Boitan B, Zugravu A, Petre N, Mircescu G.
    Iran J Kidney Dis; 2020 Dec; 14(6):470-477. PubMed ID: 33277451
    [Abstract] [Full Text] [Related]

  • 39. Plasma neutrophil gelatinase-associated lipocalin as a potential predictor of adverse renal outcomes in immunoglobulin A nephropathy.
    Park GY, Yu CH, Kim JS, Kang YJ, Kwon O, Choi JY, Cho JH, Kim CD, Kim YL, Park SH.
    Korean J Intern Med; 2015 May; 30(3):345-53. PubMed ID: 25995665
    [Abstract] [Full Text] [Related]

  • 40. High serum and urine neutrophil gelatinase-associated lipocalin levels are independent predictors of renal progression in patients with immunoglobulin A nephropathy.
    Rhee H, Shin N, Shin MJ, Yang BY, Kim IY, Song SH, Lee DW, Lee SB, Kwak IS, Seong EY.
    Korean J Intern Med; 2015 May; 30(3):354-61. PubMed ID: 25995666
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 40.